Zoetis | ZTS - Loan Capital

Stock Price
77.72
Daily Change
3.50 4.72%
Monthly
-36.67%
Yearly
-52.59%
Q2 Forecast
72.73

Zoetis reported $9.04B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Align Technology USD 0 0 Dec/2024
Bayer EUR 30.68B 1.15B Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Dentsply International USD 2.01B 9M Mar/2026
Eli Lilly USD 39.37B 1.5B Mar/2026
Henry Schein USD 2.33B 17M Mar/2026
Idexx Laboratories USD 299.85M 74.99M Mar/2026
Illumina USD 1.49B 0 Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Laboratory Of America USD 5.9B 748.3M Mar/2026
Merck USD 46.67B 77M Mar/2026
Neogen USD 793.3M 374K Dec/2025
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.62B 17.5M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Quest Diagnostics USD 5.16B 12M Mar/2026
Sanofi EUR 13.84B 1.88B Mar/2026
Sanofi EUR 15.72B 150.06M Dec/2025
Zoetis USD 9.04B 3M Mar/2026